Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 70

The DOI matches its Crossref record.

Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus

Malbruny, Brigitte, Canu, Annie, Bozdogan, Bülent, Fantin, Bruno, Zarrouk, Virginie, Dutka-Malen, Sylvie, Feger, Celine, Leclercq, Roland·2002·Antimicrobial Agents and Chemotherapy

Abstract

The mechanism of resistance to the streptogramin antibiotics quinupristin and dalfopristin was studied in a Staphylococcus aureus clinical isolate selected under quinupristin-dalfopristin therapy, in four derivatives of S. aureus RN4220 selected in vitro, and in a mutant selected in a model of rabbit aortic endocarditis. For all strains the MICs of erythromycin, quinupristin, and quinupristin-dalfopristin were higher than those for the parental strains but the MICs of dalfopristin and lincomycin were similar. Portions of genes for domains II and V of 23S rRNA and the genes for ribosomal proteins L4 and L22 were amplified and sequenced. All mutants contained insertions or deletions in a protruding β hairpin that is part of the conserved C terminus of the L22 protein and that interacts with 23S rRNA. Susceptible S. aureus RN4220 was transformed with plasmid DNA encoding the L22 alteration, resulting in transformants that were erythromycin and quinupristin resistant. Synergistic ribosomal binding of streptogramins A and B, studied by analyzing the fluorescence kinetics of pristinamycin I A-ribosome complexes, was abolished in the mutant strain, providing an explanation for quinupristin-dalfopristin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.46.7.2200-2207.2002

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 44

  1. 10.1128/AAC.40.11.2523 · DOI
  2. 10.1128/AAC.39.9.2027 · DOI
  3. 10.1016/S0378-1119(97)00464-2 · DOI
  4. 10.1128/AAC.42.7.1794 · DOI
  5. 10.1016/0378-1119(92)90488-B · DOI
  6. 10.1016/0147-619X(88)90034-0 · DOI
  7. 10.1016/0378-1119(93)90350-C · DOI
  8. Apirion, D. 1967. Three genes that affect Escherichia coli ribosomes. J. Mol. Biol.30:255-275.
  9. Aumercier, M., S. Bouhallab, M. L. Capmau, and F. Le Goffic. 1992. RP 59500: a proposed mechanism for its bactericidal activity. J. Antimicrob. Chemother.30(Suppl. A):9-14. · DOI
  10. 10.1126/science.289.5481.905 · DOI · Paper page
  11. 10.1517/13543784.7.4.591 · DOI
  12. Beyer, D., P. Vannuffel, and K. Pepper. 1998. Quinupristin (RP 57669): a new tool to investigate ribosome-group B streptogramin interactions. Biol. Chem.379:841-846. · doi:10.1515/bchm.1998.379.7.841
  13. 10.1128/AAC.43.11.2720 · DOI
  14. 10.1128/AAC.46.1.125-131.2002 · DOI · Paper page
  15. 10.1128/jb.176.20.6192-6198.1994 · DOI
  16. Cocito, C., and G. Chinali. 1985. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems. J. Antimicrob. Chemother.16(Suppl. A):35-52. · DOI
  17. Cocito, C., and M. Di Giambattista. 1978. The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. Mol. Gen. Genet.166:53-59. · doi:10.1007/bf00379729
  18. Comité de l'Antibiogramme de la Société Française de Microbiologie. 1996. 1996 report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Technical recommendations for in vitro susceptibility testing. Clin. Microbiol. Infect.2(Suppl. 1):11-25. · doi:10.1111/j.1469-0691.1996.tb00871.x
  19. Contreras, A., and D. Vazquez. 1977. Synergistic interaction of the streptogramins with the ribosome. Eur. J. Biochem.74:549-551. · doi:10.1111/j.1432-1033.1977.tb11423.x
  20. 10.1128/AAC.45.1.319-323.2001 · DOI
  21. 10.1016/S0021-9258(18)47454-6 · DOI
  22. Di Giambattista, M., E. Nyssen, A. Pecher, and C. Cocito. 1990. Affinity labeling of the virginiamycin S binding site on bacterial ribosome. Biochemistry29:9203-9211. · doi:10.1021/bi00491a014
  23. 10.1016/S0732-8893(99)00154-6 · DOI
  24. El Solh, N., and J. Allignet. 1998. Staphylococcal resistance to streptogramins and related antibiotics. Drug Res. Updates1:169-175. · doi:10.1016/s1368-7646(98)80036-8
  25. 10.1016/S1097-2765(01)00293-3 · DOI · Paper page
  26. 10.1006/jmbi.1999.2839 · DOI
  27. 10.1002/elps.1150181505 · DOI · Paper page
  28. 10.1093/clinids/10.4.867 · DOI · Paper page
  29. 10.1128/AAC.39.7.1505 · DOI
  30. 10.1038/305709a0 · DOI · Paper page
  31. Krogstad, D. J., and R. C. Moellering, Jr. 1986. Antimicrobial combinations, p. 537-595. In V. Lorian (ed.), Antibiotics in laboratory medicine, 2nd ed. Williams & Wilkins, Baltimore, Md.
  32. 10.1128/AAC.43.5.1062 · DOI · Paper page
  33. Low, D. E. 1995. Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience. Microb. Drug Resist.1:223-234. · DOI
  34. Mukhtar, T. A., K. P. Koteva, D. W. Hughes, and G. D. Wright. 2001. Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis. Biochemistry40:8877-8886. · DOI
  35. 10.1126/science.289.5481.920 · DOI · Paper page
  36. Nyssen, E., M. Di Giambattista, and C. Cocito. 1989. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. Biochim. Biophys. Acta1009:39-46. · DOI
  37. Parfait, R., M. Di Giambattista, and C. Cocito. 1981. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit. Biochim. Biophys. Acta654:236-241. · DOI
  38. 10.1042/bst0240274 · DOI · Paper page
  39. 10.1016/S0378-1119(96)00554-9 · DOI
  40. 10.1128/AAC.40.11.2562 · DOI · Paper page
  41. Unge, J., A. Aberg, S. Al-Kharadaghi, A. Nikulin, S. Nikonov, N. Davydova, N. Nevskaya, M. Garber, and A. Liljas. 1998. The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistance. Structure6:1577-1586. · DOI
  42. Vannuffel, P., M. Di Giambattista, and C. Cocito. 1992. The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J. Biol. Chem.267:16114-16120. · DOI
  43. 10.1128/AAC.45.1.1-12.2001 · DOI · Paper page
  44. 10.1128/AAC.44.5.1168-1173.2000 · DOI

Cited by

See all 70

Metadata

Authors
Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R.
Affiliations
  • Service de Microbiologie, CHU de Caen
  • UFR Pharmacie, Caen
  • INSERM EMI9933 and Bichat University, Paris
  • Anti-Infective Clinical Research, Aventis, Vitry-sur-Seine, France
Venue
Antimicrobial Agents and Chemotherapy
Published
2002-07
Volume
46
Issue
7
Pages
2200-2207
ISSN
  • 0066-4804
  • 1098-6596
Cited by
70
References
0
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus. https://app.cochat.ai/papers/10.1128/aac.46.7.2200-2207.2002
The paper
Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R. (2002). Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.46.7.2200-2207.2002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.